Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-10

Clinical Trial Update: Magnetic Seizure Therapy (MST) for the Treatment of Major Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Magnetic Seizure Therapy for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnetic Seizure Therapy

Snippet

Sponsor: Sarah Lisanby | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED